BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19841038)

  • 1. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
    Favier B; Lemaoult J; Lesport E; Carosella ED
    FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis.
    Chen LJ; Han ZQ; Zhou H; Zou L; Zou P
    Placenta; 2010 Jun; 31(6):519-27. PubMed ID: 20430441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of the CD160 activating NK cell receptor leads to its association with CD2 in circulating human NK cells.
    Rabot M; Bensussan A; Le Bouteiller P
    Transpl Immunol; 2006 Dec; 17(1):36-8. PubMed ID: 17157212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.
    Baudhuin J; Lesport E; Sousa S; Migraine J; Vigneron J; Lemaoult J; Carosella ED; Mooney N; Favier B
    Eur J Immunol; 2012 Mar; 42(3):700-9. PubMed ID: 22144141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine nitration in the human leucocyte antigen-G-binding domain of the Ig-like transcript 2 protein.
    Díaz-Lagares A; Alegre E; Arroyo A; Corrales FJ; González A
    FEBS J; 2009 Aug; 276(15):4233-43. PubMed ID: 19583775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the NK cell immunological synapse.
    Sanborn KB; Rak GD; Mentlik AN; Banerjee PP; Orange JS
    Methods Mol Biol; 2010; 612():127-48. PubMed ID: 20033638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human melanoma cell secreting human leukocyte antigen-G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell.
    Lesport E; Baudhuin J; LeMaoult J; Sousa S; Doliger C; Carosella ED; Favier B
    Hum Immunol; 2009 Dec; 70(12):1000-5. PubMed ID: 19654030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse.
    Yu Y; Wang Y; Feng M
    Hum Immunol; 2008 Jan; 69(1):16-23. PubMed ID: 18295671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
    Söderström K; Corliss B; Lanier LL; Phillips JH
    J Immunol; 1997 Aug; 159(3):1072-5. PubMed ID: 9233599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
    Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
    Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?
    Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED
    Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.